Delivery Order SPE2DR25D3015-SPE2DR26F4FB6
- Not listed
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 28, 2025, for the supply of Adderall XR 30 mg capsules (100 count) with a ceiling value of $2,144.00 and a completion date of December 1, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation and will be performed at the contractor's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value transaction typical of...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a contract ceiling value of $1,020.45. This competitively awarded, non-set-aside delivery order represents a firm fixed-price transaction with an ultimate completion date of November 6, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania, where the company...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a contract ceiling value of $2,862.68. This is a firm fixed price delivery order with an ultimate completion date of November 6, 2025, and represents a non-set-aside competitive award. The work will be performed in Conshohocken, Pennsylvania, where AmerisourceBergen maintains its corporate headquarters. This delivery order...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall XR 10 mg capsules (100-count units) with a ceiling value of $2,508.14. This non-set-aside contract utilizes firm fixed pricing and represents a delivery order under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical (SPE2DX), valued at $999,999,999.00 and extending through December 2026. The order is scheduled for completion by...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on October 24, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,156.08. This is a firm fixed-price delivery order with an ultimate completion date of October 27, 2025, and represents a non-competitive set-aside award. The order will be fulfilled from AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on November 13, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $2,962.05. This is a firm fixed-price delivery order with no set-aside designation, reflecting a competitively awarded contract to support federal medical procurement needs. The order is scheduled for ultimate completion by November 14, 2025, with performance taking place at AmerisourceBergen's...
- The Defense Logistics Agency (DLA) awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100 count) with a ceiling value of $18,892.20. This firm fixed-price delivery order, with an ultimate completion date of December 5, 2025, represents a competitively awarded, non-set-aside contract with performance taking place at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The delivery order falls under the...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 5, 2025, for the supply of Adderall XR 10 mg capsules (100 count) with a ceiling value of $2,351.70. This competitive award carries a firm fixed price structure and is scheduled for completion by December 8, 2025. The order will be fulfilled from the vendor's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite Delivery...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 4, 2025, for the supply of Adderall XR 20 mg capsules (100-count units) with a ceiling value of $1,457.08. This non-set-aside, firm fixed-price delivery order is scheduled for completion by December 5, 2025, and will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. The award represents a small-value pharmaceutical procurement supporting federal medical...
- The Defense Logistics Agency awarded AmerisourceBergen Drug Corp a delivery order valued at $2,312.16 on December 1, 2025, for the supply of Adderall XR 30 mg capsules (100-count units). This is a firm fixed-price, competitively awarded delivery order with no set-aside designation and an ultimate completion date of December 2, 2025. The contract will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under...
- SPE2DR25D3015Indefinite Delivery Contract
- SPE2DR25D3015-SPE2DR26F4FB6Delivery Order
The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on December 3, 2025, for the supply of Adderall XR 30 mg capsules (100-count units) with a ceiling value of $1,245.60. This firm fixed-price delivery order, with an ultimate completion date of December 4, 2025, represents a non-competitive set-aside award and is performed from the vendor's corporate office location in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (contract SPE2DX), a comprehensive global pharmaceutical support vehicle valued at $999,999,999.00 and extending through December 2026. AmerisourceBergen Drug Corp, one of the nation's largest pharmaceutical distributors, serves as a critical vendor for federal medical procurement and maintains an extensive portfolio of delivery orders through the Defense Logistics Agency's Medical Supply Chain. The company supplies a wide range of pharmaceutical products to support military healthcare programs, the Defense Health Agency, U.S. Coast Guard, and other federal healthcare systems. This delivery order for controlled-substance medication reflects the company's ongoing role in fulfilling essential pharmaceutical requirements for the Department of Defense medical infrastructure.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.2k | 12/2/25 |